Clinical Trial: Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial

Brief Summary: To determine whether the use of two antiviral agents in combination will be better than placebo in the treatment of an inflammatory sidease of the spinal cord caused by HTLV-I